Where Discovery Leads is a multimedia storytelling project that delves into key research themes at CHOP Research Institute. This is part one of a three-part series that focuses on novel diagnostic tools and approaches being developed under the leadership of the Center for Autism Research at CHOP. See part 2 and part 3 of the series.
Children’s Hospital of Philadelphia (CHOP) today joins with other research leaders in celebrating the U.S. Food and Drug Administration’s (FDA) approval of Spark Therapeutics’ innovative gene therapy for the treatment of a rare, inherited form of retinal blindness.
September marks National Childhood Cancer Awareness Month, and this year at Children's Hospital of Philadelphia, we kick-started the commemorative period on the heels of exciting news about breakthroughs in pediatric cancer immunotherapy research.